Board of County Commissioners Reports
September 10, 2024 - the Board approved allocation of Washoe Opioid Abatement and Recovery Fund (WOARF) non-bankruptcy funds through the One Nevada Agreement, in the total amount of $4,009,786, to the following six projects awarded:
July 16, 2024 – the Board approved the Settlement between Kroger and the State of Nevada is in an amount of $26,718,162 before attorney’s fees are deducted and paid over a 10-year period. Pursuant to the One Nevada Agreement, Washoe County will receive an estimated annual allocation of $100,043.47 for 10 years.
January 23, 2024 - the Board approved the creation of one new full-time Grants and Community Program Analyst position, pay grade 16 (Office of the County Manager), upon evaluation and approval by the Job Evaluation Committee (JEC); and authorize Human Resources to make the necessary changes; 100% funded by Opioid Settlement funds [Estimated annual costs $125,687; Fiscal Year 2024 impact $62,844].
November 14, 2023 – the Board approved the Settlement between the State of Nevada and Masters Pharmaceutical, LLC in the amount of $1,428,552.26 before attorney’s fees. Pursuant to the One Nevada Agreement, Washoe County will receive an estimated total net allocation of $54,819.67.
September 12, 2023 – the Board approved the Settlement between the State of Nevada and Teva in the amount of $193,985,662.29 and between the State of Nevada and Walgreens in the amount of $285,000,000, before attorney’s fees and costs are deducted, pursuant to the One Nevada Agreement.
April 25, 2023 – the Board approved the Settlement between the State of Nevada and Allergan in the amount of $26,508,913.00 and between the State of Nevada and CVS in the amount of $151,858,772.26 pursuant to the One Nevada Agreement.
February 21, 2023 – the Board approved the Settlement between the State of Nevada and Walmart in the amount of $32,231,037.14 pursuant to the One Nevada Agreement.
June 21, 2022 – the Board approved "Amendment No. 2 to One Nevada Agreement on Allocation of Opioid Recoveries" which allows the Nevada Attorney General’s Office to divide the Recoveries in accordance with the percentages and terms of the One Nevada Agreement and remit payments to Local Governments and attorneys’ fees to the appropriate Counsel on behalf of the Local Governments. Recoveries means settlement payments totaling $285,679,409.03 from opioids distributor defendants AmerisourceBergen Drug Corporation, Cardinal Health, and McKesson, and opioid manufacturer defendant Janssen/Johnson & Johnson to compensate for the effects of the nationwide opioid crisis.
July 27, 2021 – the Board approved the One Nevada Agreement which provides the allocation model for distribution of any monetary recovery from the defendants between all governmental entities within the state of Nevada.
June 8, 2021 - the Board received an update on the litigation and bankruptcy cases involving the various opioid defendants and took action to direct counsel for Washoe County to cast its vote to approve a bankruptcy plan consistent with other members of the Multi-State Government Entities (“MSGE”) in the Purdue Pharma Bankruptcy Case No. 19-23649 filed in the United States Bankruptcy Court Southern District of New York.
March 26, 2019 - the Board approved an agreement for legal services of Eglet Prince, LLP and Bradley, Drendel & Jeanney as for outside counsel to represent the County against of manufacturers, distributors and dispensers of opioid-based drugs, and to authorize the filing of actions against such entities. The agreement provided that outside counsel would receive Twenty-Five (25%) of the recovery.
For questions, please contact WOARF at WOARF@WashoeCounty.gov